This document summarizes the services and corporate structure of a stem cell company. It describes the costs and timelines for establishing a tissue bank and clinical facility for research and regenerative treatments. It also shows the company's corporate structure with divisions for cosmetics, exosome treatments, and medical treatments distributed in the US, Mexico and internationally.